Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin beta-10 (PCDHB10) is a member of the protocadherin beta gene cluster located on human chromosome 5, encoding a neural cadherin-like cell adhesion protein that is an integral plasma membrane component[3][5][1]. This protein contains six extracellular cadherin domains and a unique cytoplasmic tail, contributing to homophilic (self-selective) interactions that guide the establishment and specificity of neural cell–cell connectivity[1][2][3][5]. Although the specific functions of PCDHB10 are not fully understood, it is believed to play a crucial role in neural development, circuit assembly, and synapse formation[1][2][7]. It is implicated in a variety of diseases, including multiple cancers (such as pancreatic ductal adenocarcinoma and glioblastoma) and neurodevelopmental disorders like autism[1][5]. No drugs are currently known to specifically target PCDHB10, and its mechanisms of therapeutic modulation remain to be established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin beta-10 (PCDHB10).